CD19CD22 CAR-T therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD19CD22 CAR-T therapy, covering 2024-04-22 to 2024-04-22. Get the full timeline:
Most recent: Clinical Trial Update: CD19CD22 CAR-T Therapy in Patients With High-Risk B Acute Lymphoblastic Leukemia (B-ALL). [Phase 2]